Induction of preprotachykinin-I and neurokinin-1 by adrenocorticotropin and prolactin. Implication for neuroendocrine-immune-hematopoietic axis

Journal of Neuroimmunology

Volumn 112, Issue 1-2, 2001, Pages 188-196

  Maloof, Paul B ^a   Joshi, Deval D ^a   Qian, Jing ^a   Gascón, Pedro ^a   Singh, Deepreet ^a   Rameshwar, Pranela ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Adrenocorticotropin; Bone marrow; Neurokinin; Prolactin; Stromal cells

Indexed keywords

CORTICOTROPIN; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR; PREPROTACHYKININ; PROLACTIN;

ARTICLE; BONE MARROW CELL; BURST FORMING UNIT E; CELL PROLIFERATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TRANSCRIPTION REGULATION;

ADRENOCORTICOTROPIC HORMONE; BONE MARROW; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; PROLACTIN; PROTEIN PRECURSORS; RNA, MESSENGER; STROMAL CELLS; TACHYKININS; TRANSCRIPTION, GENETIC;

EID: 0035212272     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00405-7     Document Type: Article

References (48)

1. Relative contributions of peripheral and central sources to levels of IL-1α in the cerebral cortex of mice: Assessment with species-specific enzyme immunoassays
2. Immune-neuroendocrine interactions: Facts and hypotheses
3. The role of stromal cell heparan sulphate in regulating haemopoiesis
4. Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma
5. Interdependence of the endocrine and immune systems
6. Psychoneuroimmunology for the psychoneuroendocrinologist: A review of animal studies of nervous system-immune system interactions
7. Granulocyte-macrophage colony formation in serum-free culture: Effects of purified colony-stimulating factors and modulation by hydrocortisone
8. The role of psychological factors in cancer incidence and prognosis
9. Identification of newly transcribed RNA
10. Medial amygdaloid suppression of predatory attack behavior in the cat: I. Role of a substance P pathway from the medial amygdala to the medial hypothalamus
11. cDNA sequence of human beta-preprotachykinin, the common precursor to substance P and neurokinin A
12. Measles virus-substance P receptor interactions. Possible novel mechanism of viral fusion
13. Substance-P receptors in human primary neoplasms: Tumoral and vascular localization
14. Human monocytes and macrophages express substance P and neurokinin-1 receptor
15. Effects of stress on the immune system
16. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
17. Structure, functions, and mechanisms of substance P receptor action
18. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS
19. Pathways and mechanisms for cytokine signaling of the central nervous system
20. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy
21. Adrenergic regulation of haematopoiesis
22. Tachykinins in the autonomic nervous system
23. Effects of neurokinin-A on the rat hypothalamo-pituitary-adrenal axis
24. The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions
25. Preprotachykinin-A gene expression occurs transiently in the developing rat endocrine pancreas and can be regulated in RINm5F cells
26. Inhibition of corticotropin releasing factor (CRF)-induced adrenocorticotropin (ACTH) secretion in pituitary corticotropic cells by substance P
27. Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease
28. Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis
29. Substance P augmentation of CSF-1-stimulated in vitro myelopoiesis: A two-signal progenitor restricted, tuftsin-like effect
30. Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis
31. Hydrocortisone promotes survival and proliferation of granulocyte-macrophage progenitors via monocytes/macrophages
32. Tachykinin receptors and receptor subtypes
33. The blood-brain barrier and the inflammatory response
34. c-kit ligand reactivates fetal hemoglobin synthesis in serum-free culture of stringently purified normal adult burst-forming unit-erythroid
35. Adhesion of monocytes from patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for IL-1 and TGF-β
36. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma. Potential autoregulatory role for these cytokines in SP receptor expression and induction
37. Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma
38. Hematopoietic regulation mediated by interactions among the neurokinins and cytokines
39. Receptor induction regulates the synergistic effects of substance P with IL-1 and PDGF on the proliferation of bone marrow fibroblasts
40. Stress and relapse of breast cancer
41. Corticosteroids alter hematopoiesis in vitro by enhancing human monocyte secretion of granulocyte colony-stimulating factor
42. Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells. Implications for bone marrow metastasis
43. Neural-immune interactions in health and disease
44. Somatostatin and the immune and haematopoetic system; a review
45. Cytokine-to-brain communication: A review and analysis of alternative mechanisms
46. Associations between the neuroendocrine and immune systems
47. On the development of bone marrow innervation in new-born rats as studied with silver impregnation and electron microscopy
48. Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine